Multicentre, prospective, assessor-blind, in parallel groups randomised and controlled trial of the efficacy and safety of betamethasone valerate 2.25mg medicated plaster (Betesil) versus 50 microg-0,5mg/g calcipotriol-betamethasone (dipropionate) ointment (Daivobet/Dovobet), in the treatment of chronic plaque psoriasis.

Trial Profile

Multicentre, prospective, assessor-blind, in parallel groups randomised and controlled trial of the efficacy and safety of betamethasone valerate 2.25mg medicated plaster (Betesil) versus 50 microg-0,5mg/g calcipotriol-betamethasone (dipropionate) ointment (Daivobet/Dovobet), in the treatment of chronic plaque psoriasis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2016

At a glance

  • Drugs Betamethasone valerate (Primary) ; Betamethasone-dipropionate/calcipotriol
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors IBSA
  • Most Recent Events

    • 17 Jan 2011 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 25 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top